Items where Author is "Wiegert, Erol"

Article

Haanen, John B. A. G. and Mackensen, Andreas and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva and Heudobler, Daniel and Borchmann, Peter and Bokemeyer, Carsten and Klobuch, Sebastian and Desuki, Alexander and Lueke, Florian and Wiegert, Erol and Schulz, Catrine and Rengstl, Benjamin and Preussner, Liane and Tuereci, Oezlem and Sahin, Ugur (2022) BNT211: A Phase I trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors. CANCER RESEARCH, 82 (12supp): CT002. ISSN 0008-5472, 1538-7445

Conference or Workshop Item

Mackensen, Andreas and Haanen, John B. A. G. and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva Maria and Heudobler, Daniel and Borchmann, Peter and Bokemeyer, Carsten and Klobuch, Sebastian and Kutsch, Nadine and Mueller, Fabian and Desuki, Alexander and Lueke, Florian and Wiegert, Erol and Flemmig, Carina and Schulz-Eying, Catrine and Rengstl, Benjamin and Preussner, Liane and Tuereci, Oezlem and Sahin, Ugur (2023) CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product. In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 02-06, 2023, Chicago, IL.

Mackensen, Andreas and Koenecke, Christian and Haanen, John and Alsdorf, Winfried and Desuki, Alexander and Wagner-Drouet, Eva and Heudobler, Daniel and Borchmann, Peter and Wiegert, Erol and Schulz, Catrine and Rengstl, Benjamin and Preussner, Liane and Tuereci, Oezlem and Sahin, Ugur (2021) BNT211: A PHASE I/II TRIAL TO EVALUATE SAFETY AND EFFICACY OF CLDN6 CAR-T CELLS AND VACCINE-MEDIATED IN VIVO EXPANSION IN PATIENTS WITH CLDN6-POSITIVE ADVANCED SOLID TUMORS. In: SITC 36th Anniversary Annual Meeting (SITC 2021), Nov. 12–14, 2021, Washington, D.C..

Other

Mackensen, Andreas and Haanen, John B. A. G. and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva and Borchmann, Peter and Heudobler, Daniel and Ferstl, Barbara and Klobuch, Sebastian and Bokemeyer, Carsten and Desuki, Alexander and Lueke, Florian and Kutsch, Nadine and Mueller, Fabian and Smit, Eveline and Hillemanns, Peter and Karagiannis, Panagiotis and Wiegert, Erol and He, Ying and Ho, Thang and Kang-Fortner, Qing and Schlitter, Anna Melissa and Schulz-Eying, Catrine and Finlayson, Andrew and Flemmig, Carina and Kuehlcke, Klaus and Preussner, Liane and Rengstl, Benjamin and Tuereci, Oezlem and Sahin, Ugur (2023) CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. NATURE PORTFOLIO, BERLIN.